Hypermucoviscous phenotype expressed by an isolate of uropathogenic escherichia coli: An overlooked and underappreciated virulence factor

Clinical Microbiology Newsletter

Volumn 32, Issue 11, 2010, Pages 81-85

  Bottone, Edward J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDIAN INK; SIDEROPHORE;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CASE REPORT; CHRONIC PYELONEPHRITIS; CONTROLLED STUDY; EMULSION; ESCHERICHIA COLI K 12; ESCHERICHIA COLI O157; GENE EXPRESSION; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL MORPHOLOGY; NEPHRECTOMY; NONHUMAN; PHENOTYPE; URINE CULTURE; UROPATHOGENIC ESCHERICHIA COLI; VISCOSITY;

EID: 77952914190     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2010.05.001     Document Type: Article

References (24)

1. Dhakal B.K., Kulesus R.R., Mulvey M.A. Mechanism and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur. J. Clin. Invest. 2008, 38(Suppl. 2):2-11.
2. Emödy L., Kerényi M., Nagy G. Virulence factors of uropathogenic Escherichia coli. Int. J. Antimicrob. Agents 2003, 22:S29-S33.
3. Sharma M.S., Aparna S.Y., Chadhary V. Biofilm production in uropathogenic Escherichia coli. Ind. J. Pathol. Microbiol. 2009, 52:294.
4. McCabe W.R., et al. The relation of K antigen to virulence of E. coli. J. Infect. 1975, 131:6-10.
5. Horowitz M.A., Silverstein S.C. Influence of Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J. Clin. Invest. 1980, 65:82-94.
6. Johnson J.R. Virulence factors in Escherichia coli urinary tract infections. Clin. Microbiol. Rev. 1991, 4:80-128.
7. Lee H.C., et al. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J. Intern. Med. 2006, 259:606-614.
8. Lin J.C., et al. High prevalence of phagocytic-resistant serotype of Klebsiella pneumoniae in liver abscess. Microbes Infect. 2004, 6:1191-1198.
9. Frazee B.W., Hansen S., Lambert L. Invasive infection with hypermucoviscous Klebsiella pneumoniae: multiple cases presenting to a single Emergency Department in the United States. Ann. Emerg. Med. 2008, 20:1-4.
10. Beiser S.M., Davis B.D. Mucoid mutants of Escherichia coli. J. Bacteriol. 1957, 74:303-307.
11. Hamelin C., Chung Y.S. Characterization of mucoid mutants of Escherichia coli K-12 isolated after exposure to ozone. J. Bacteriol. 1975, 122:19-24.
12. Markowitz A. Regulatory mechanisms for synthesis of capsular polysaccharide in mucoid mutants of Escherichia coli K 12. Proc. Natl. Acad. Sci. USA 1964, 51:239-246.
13. Kilbourn J.P., Grach J.L., Campbell R.A. An atypical Escherichia coli associated with cystic fibrosis of the pancreas. J. Pediatr. 1968, 73:408-411.
14. Macone A.B., et al. Mucoid Escherichia coli in cystic fibrosis. N. Engl. J. Med. 1981, 304:1445-1449.
15. Junkins A.D., Doyle M.P. Demonstration of exopolysaccharide production by Enterohemorrhagic Escherichia coli. Curr. Microbiol. 1992, 25:8-17.
16. Chen, J., S.M. Lee, and Y. Mao. 2004. Protective effect of exopolysaccharide colonic acid of Escherichia coli O157:H7 to osmotic and oxidative stress.
17. Lee S.M., Chen J. Survival of Escherichia coli O157:H7 in set yogurt as influenced by the production of an exopolysaccharide, colonic acid. J. Food Prot. 2004, 67:252-255.
18. Aslam S. Effect of antibacterials on biofilms. Am. J. Infect. Control 2008, 36:S175.e9-S175.e11.
19. Mulvey M.A., et al. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA 2000, 97:8829-8835.
20. Morishita H., Torii T. Studies on the non-motile Escherichia coli with mucoid forming colony isolated from urological infection. Nippon Hinyokika Gakkai Zasshi 1986, 77:1139-1144.
21. Raksha R., Srinivasa H., Macaden R.S. Occurrence and characterization of uropathogenic Escherichia coli in urinary tract infections. Ind. J. Med. Microbiol. 2003, 21:102-107.
22. Fang C.T., et al. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 2004, 199:697-705.
23. Chuang Y.P., et al. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J. Infect. Dis. 2006, 193:645-654.
24. Arakawa Y.M., et al. Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid 01:k2. Infect. Immun. 1991, 59:2043-2050.